These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8100564)

  • 1. Genetic alterations in thyroid tumor progression: association with p53 gene mutations.
    Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi Y; Dohi K; Nakamura N; Akiyama M
    Jpn J Cancer Res; 1993 May; 84(5):526-31. PubMed ID: 8100564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unique association of p53 mutations with undifferentiated carcinoma of the thyroid].
    Ito T; Seyama T; Hayashi Y; Dohi K; Akiyama M
    Nihon Rinsho; 1994 Apr; 52(4):1069-74. PubMed ID: 8196165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.
    Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi T; Hayashi Y; Dohi K; Nakamura N; Akiyama M
    Cancer Res; 1992 Mar; 52(5):1369-71. PubMed ID: 1737400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
    Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
    J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.
    Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of p53 gene mutation with pathological characteristics and prognosis of thyroid carcinoma].
    Song Y; Wang L; Huang G; Yuan S; Xiao L
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):298-9, 314. PubMed ID: 12545813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
    Nikiforov YE
    Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
    Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
    J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in all stages of thyroid carcinomas.
    Zou M; Shi Y; Farid NR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of p16/CDKN2 alterations in thyroid carcinomas.
    Yane K; Konishi N; Kitahori Y; Naito H; Okaichi K; Ohnishi T; Miyahara H; Matsunaga T; Hiasa Y
    Cancer Lett; 1996 Mar; 101(1):85-92. PubMed ID: 8625287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas.
    Dobashi Y; Sugimura H; Sakamoto A; Mernyei M; Mori M; Oyama T; Machinami R
    Diagn Mol Pathol; 1994 Mar; 3(1):9-14. PubMed ID: 8162258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.
    Soares P; Trovisco V; Rocha AS; Feijão T; Rebocho AP; Fonseca E; Vieira de Castro I; Cameselle-Teijeiro J; Cardoso-Oliveira M; Sobrinho-Simões M
    Virchows Arch; 2004 Jun; 444(6):572-6. PubMed ID: 15095090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours.
    Salvatore D; Celetti A; Fabien N; Paulin C; Martelli ML; Battaglia C; Califano D; Monaco C; Viglietto G; Santoro M; Fusco A
    Eur J Endocrinol; 1996 Feb; 134(2):177-83. PubMed ID: 8630516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
    Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
    Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutation in thyroid carcinoma.
    Ho YS; Tseng SC; Chin TY; Hsieh LL; Lin JD
    Cancer Lett; 1996 May; 103(1):57-63. PubMed ID: 8616809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
    Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.
    Wright PA; Lemoine NR; Goretzki PE; Wyllie FS; Bond J; Hughes C; Röher HD; Williams ED; Wynford-Thomas D
    Oncogene; 1991 Sep; 6(9):1693-7. PubMed ID: 1923534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines.
    Jossart GH; Epstein HD; Shaver JK; Weier HU; Greulich KM; Tezelman S; Grossman RF; Siperstein AE; Duh QY; Clark OH
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3498-504. PubMed ID: 8855792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.